{"ageusia": 3.24, "anosmia": 16.62, "asthma": 19.71, "asthmatic crisis": 28.55, "cataract": 4.46, "chronic obstructive pulmonary disease": 6.97, "condition aggravated": 2.54, "cough": 3.1, "drug hypersensitivity": 3.53, "dysphonia": 2.2, "dyspnoea": 2.76, "dyspnoea exertional": 6.74, "eczema": 7.7, "epistaxis": 13.94, "full blood count abnormal": 50.24, "gastrooesophageal reflux disease": 5.74, "glaucoma": 13.82, "incorrect dose administered": 2.33, "intraocular pressure increased": 13.95, "loss of personal independence in daily activities": 10.09, "macular degeneration": 50.92, "nasal congestion": 15.37, "nasal discomfort": 42.31, "nasal dryness": 33.61, "nasal obstruction": 85.41, "nasal polyps": 112.38, "nsaid exacerbated respiratory disease": 1865.33, "obstructive airways disorder": 50.8, "oral candidiasis": 10.78, "paraesthesia oral": 2.59, "proctitis": 37.53, "product complaint": 35.02, "product prescribing issue": 29.1, "product use in unapproved indication": 2.89, "productive cough": 7.04, "respiratory tract infection": 6.62, "rhinalgia": 64.08, "rhinitis": 5.72, "rhinitis allergic": 19.55, "rhinorrhoea": 7.17, "secretion discharge": 39.5, "sinusitis": 8.46, "sleep apnoea syndrome": 18.16, "sleep disorder": 2.07, "sleep disorder due to a general medical condition": 94.41, "sneezing": 6.84, "sputum discoloured": 24.29, "swelling face": 2.53, "therapeutic product effect incomplete": 25.42, "throat clearing": 148.97, "throat irritation": 5.6, "visual acuity reduced": 2.53, "visual impairment": 2.08, "wheezing": 19.08}